Search results
Results from the WOW.Com Content Network
On October 7, 2022, Pfizer's new bivalent vaccine, which targeted the original strain of SARS-CoV-2 as well as the Omicron BA.4 and BA.5 subvariants, was approved by Health Canada for individuals aged 12 years and up. According to Health Canada, 97% of COVID-19 cases in Canada were either of the BA.4 or BA.5 subvariant as of mid-September 2022.
Users of this vaccine passport, the first in Canada, faced fewer COVID-19 public health restrictions. [2] By early July, the demand for the paper vaccine passports temporarily overwhelmed the system. At the same time, the province reached a new "marker in the pandemic"—the COVID-19 vaccines supply exceeded "demand on a daily basis." [2] [44]
COVID-19 vaccinations in Canada by province and territory, September 30, 2022 (Province Population People who have at least one dose People fully vaccinated
The COVID-19 pandemic in Canada is part of the ongoing worldwide pandemic of coronavirus disease 2019 . It is caused by severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ). Most cases over the course of the pandemic have been in Ontario , Quebec , British Columbia and Alberta .
On March 20, the Illinois Department of Public Health announced that there was an increase of 163 new cases along with the death of a woman in her 70s in Cook County. [52] The age range for those with confirmed contraction of the COVID-19 disease was from 3 to 99.
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
On January 28, 2020, British Columbia became the second province to confirm a case of COVID-19 in Canada. [2] The first case of infection involved a patient who had recently returned from Wuhan, Hubei, China. [3] The first case of community transmission in Canada was confirmed in British Columbia on March 5, 2020. [4]
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.